Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Blood (2025) 145 (14): 1526–1535.

https://doi.org/10.1182/blood.2024026401

Published: 2025

Includes: Supplemental data

Journal Articles

Long Term Follow-up of Methotrexate and Cytarabine in Adult Patients with Langerhans Cell Histiocytosis

He Lin, Xin-xin Cao, Long Chang, Min Lang, Zheng-Zheng Liu, Minghui Duan, Daobin Zhou, Wen Gao

Blood (2024) 144 (Supplement 1): 3166.

https://doi.org/10.1182/blood-2024-199099

Published: 2024

Journal Articles

Modified Staging System for Patients with Waldenstrom's Macroglobulinemia in a Chinese Cohort

Jia Chen, Jian Li, Daobin Zhou, Xinxin Cao

Blood (2024) 144 (Supplement 1): 6892.

https://doi.org/10.1182/blood-2024-210305

Published: 2024

Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Gemcitabine, Cisplatin and Dexamethasone in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma: A Phase I Study

Chong Wei, Shengyu Zhou, Shuangnian Xu, Hongmei Jing, Hui Liu, Wei Zhang, Daobin Zhou

Blood (2024) 144 (Supplement 1): 1691.

https://doi.org/10.1182/blood-2024-209576

Published: 2024

Journal Articles

Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China

Zhangyuting He, Huiying Zhu, Chong Wei, Danqing Zhao, Wei Wang, Jian Li, Wei Zhang, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6504.

https://doi.org/10.1182/blood-2024-203008

Published: 2024

Journal Articles

The Clinical Characteristics and Prognostic Analysis of Prolonged Cytopenia after CAR-T Cell Therapy

Huiying Zhu, Danqing Zhao, Zhe Zhuang, Chao Chen, Wei Zhang, Daobin Zhou, Jian Li, Yan Zhang

Blood (2024) 144 (Supplement 1): 7148.

https://doi.org/10.1182/blood-2024-207024

Published: 2024

Journal Articles

Chemo-Free Salvage Treatment Is Better Than Traditional Chemotherapy in Relapsed/Refractory Subcutaneous Panniculitis-like T-Cell Lymphoma

Chao Chen, Jingjing Yin, Minghui Duan, Chong Wei, Congwei Jia, Wei Zhang, Jian Li, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6400.

https://doi.org/10.1182/blood-2024-203578

Published: 2024

Journal Articles

CHOP Is Insufficient for Newly-Diagnosed Subcutaneous Panniculitis-like T-Cell Lymphoma Patients: A Retrospective Study of 32 Patients in China

Chao Chen, Jingjing Yin, Wei Wang, Danqing Zhao, Chong Wei, Cong-Wei Jia, Wei Zhang, Jian Li, Daobin Zhou, Yan Zhang

Blood (2024) 144 (Supplement 1): 6395.

https://doi.org/10.1182/blood-2024-202966

Published: 2024

Journal Articles

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Blood (2023) 142 (Supplement 1): 1025.

https://doi.org/10.1182/blood-2023-182817

Published: 2023

Journal Articles

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenström's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results

Blood (2023) 142 (Supplement 1): 3039.

https://doi.org/10.1182/blood-2023-181500

Published: 2023

Journal Articles

Rituximab Plus Bortezomib for Refractory and Relapsed Warm Autoimmune Hemolytic Anemia：a Prospective, Single-Arm, Phase Ⅱ Trial

Xijuan Lin, Chen Yang, Junling Zhuang, Daobin Zhou, Miao Chen, Bing Han

Blood (2023) 142 (Supplement 1): 3829.

https://doi.org/10.1182/blood-2023-178625

Published: 2023

Journal Articles

Adult Langerhans Cell Histiocytosis with Liver Involvement

Long Chang, Lin He, Huacong Cai, Minghui Duan, Jian Li, Daobin Zhou, Gaurav Goyal, Xinxin Cao

Blood (2023) 142 (Supplement 1): 3197.

https://doi.org/10.1182/blood-2023-184790

Published: 2023

Journal Articles

Clinical Characteristics, Genomic Profiling and Outcomes of Langerhans Cell Histiocytosis in Adults with Single System Multifocal Disease

Hong-Xiao Han, Long Chang, Min Lang, Lin He, Jian Li, Minghui Duan, Daobin Zhou, Xinxin Cao, Wen Gao

Blood (2023) 142 (Supplement 1): 1165.

https://doi.org/10.1182/blood-2023-178177

Published: 2023

Journal Articles

Lenalidomide and Dexamethasone for Patients with Rosai-Dorfman Disease: A Single Arm, Single Center, Prospective Phase 2 Study

Long Chang, Lin He, Jian Li, Daobin Zhou, Xinxin Cao, Wen Gao

Blood (2023) 142 (Supplement 1): 6331.

https://doi.org/10.1182/blood-2023-184621

Published: 2023

Journal Articles

Efficacy and Safety of Peginterferon Alfa-2b in 95 Patients with Myeloproliferative Neoplasms:a Single Center Retrospective Analysis

Long Chang, Hao Cai, Xinxin Cao, Jian Li, Daobin Zhou, Minghui Duan

Blood (2022) 140 (Supplement 1): 12244.

https://doi.org/10.1182/blood-2022-168360

Published: 2022

Journal Articles

Long-Term Outcomes of Second-Line Vs Later-Line Zanubrutinib Treatment in Patients with Relapsed/Refractory MCL: An Updated Pooled Analysis

Blood (2022) 140 (Supplement 1): 6501–6503.

https://doi.org/10.1182/blood-2022-162135

Published: 2022

Journal Articles

Phase Ib/II Study of Rituximab, Lenalidomide and Methotrexate Followed By Lenalidomide Maintenance in Patients with Newly Diagnosed Primary CNS Lymphoma: The Remla Trial

Yan Zhang, Wei Wang, Jian Li, Daobin Zhou, Wei Zhang, Danqing Zhao, Chong Wei, Lu Zhang, Xinxin Cao

Blood (2022) 140 (Supplement 1): 6608–6609.

https://doi.org/10.1182/blood-2022-165934

Published: 2022

Journal Articles

Efficacy and Safety of Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Patients with Mayo 2004 Stage 3 Light-Chain Amyloidosis: A Prospective Phase 2 Study

Ya-Juan Gao, Kaini Shen, Long Chang, Jun Feng, Yueying Mao, Lu Zhang, Xinxin Cao, Daobin Zhou, Jian Li

Blood (2022) 140 (Supplement 1): 4391–4392.

https://doi.org/10.1182/blood-2022-157044

Published: 2022

Journal Articles

A Multicenter, Phase III Study of Chidamide, Azacitidine Combined with CHOP Versus CHOP in Patients with Untreated Peripheral T-Cell Lymphoma

Chong Wei, Yan Zhang, Jian Li, Wei Zhang, Daobin Zhou

Blood (2022) 140 (Supplement 1): 6567–6568.

https://doi.org/10.1182/blood-2022-157899

Published: 2022

Journal Articles

Myc Translocation Is an Adverse Factor Redefining High-Risk Multiple Myeloma

Xianghong Jin, Jianhua Du, Fujing Zhang, Hui Li, Shuangjiao Liu, Chen Yang, Miao Chen, Daobin Zhou, Junling Zhuang

Blood (2022) 140 (Supplement 1): 12575.

https://doi.org/10.1182/blood-2022-169332

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Long Term Follow-up of Methotrexate and Cytarabine in Adult Patients with Langerhans Cell Histiocytosis

Modified Staging System for Patients with Waldenstrom's Macroglobulinemia in a Chinese Cohort

Combination of Mitoxantrone Hydrochloride Liposome with Gemcitabine, Cisplatin and Dexamethasone in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma: A Phase I Study

Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China

The Clinical Characteristics and Prognostic Analysis of Prolonged Cytopenia after CAR-T Cell Therapy

Chemo-Free Salvage Treatment Is Better Than Traditional Chemotherapy in Relapsed/Refractory Subcutaneous Panniculitis-like T-Cell Lymphoma

CHOP Is Insufficient for Newly-Diagnosed Subcutaneous Panniculitis-like T-Cell Lymphoma Patients: A Retrospective Study of 32 Patients in China

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenström's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results

Rituximab Plus Bortezomib for Refractory and Relapsed Warm Autoimmune Hemolytic Anemia：a Prospective, Single-Arm, Phase Ⅱ Trial

Adult Langerhans Cell Histiocytosis with Liver Involvement

Clinical Characteristics, Genomic Profiling and Outcomes of Langerhans Cell Histiocytosis in Adults with Single System Multifocal Disease

Lenalidomide and Dexamethasone for Patients with Rosai-Dorfman Disease: A Single Arm, Single Center, Prospective Phase 2 Study

Efficacy and Safety of Peginterferon Alfa-2b in 95 Patients with Myeloproliferative Neoplasms:a Single Center Retrospective Analysis

Long-Term Outcomes of Second-Line Vs Later-Line Zanubrutinib Treatment in Patients with Relapsed/Refractory MCL: An Updated Pooled Analysis

Phase Ib/II Study of Rituximab, Lenalidomide and Methotrexate Followed By Lenalidomide Maintenance in Patients with Newly Diagnosed Primary CNS Lymphoma: The Remla Trial

Efficacy and Safety of Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Patients with Mayo 2004 Stage 3 Light-Chain Amyloidosis: A Prospective Phase 2 Study

A Multicenter, Phase III Study of Chidamide, Azacitidine Combined with CHOP Versus CHOP in Patients with Untreated Peripheral T-Cell Lymphoma

Myc Translocation Is an Adverse Factor Redefining High-Risk Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only